Correlation Between Veracyte and Sage Therapeutic
Can any of the company-specific risk be diversified away by investing in both Veracyte and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Sage Therapeutic, you can compare the effects of market volatilities on Veracyte and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Sage Therapeutic.
Diversification Opportunities for Veracyte and Sage Therapeutic
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and Sage is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of Veracyte i.e., Veracyte and Sage Therapeutic go up and down completely randomly.
Pair Corralation between Veracyte and Sage Therapeutic
Given the investment horizon of 90 days Veracyte is expected to generate 0.82 times more return on investment than Sage Therapeutic. However, Veracyte is 1.22 times less risky than Sage Therapeutic. It trades about 0.16 of its potential returns per unit of risk. Sage Therapeutic is currently generating about -0.1 per unit of risk. If you would invest 2,181 in Veracyte on September 3, 2024 and sell it today you would earn a total of 2,114 from holding Veracyte or generate 96.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Sage Therapeutic
Performance |
| Timeline |
| Veracyte |
| Sage Therapeutic |
Veracyte and Sage Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Sage Therapeutic
The main advantage of trading using opposite Veracyte and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Sage Therapeutic vs. Apellis Pharmaceuticals | Sage Therapeutic vs. Terns Pharmaceuticals | Sage Therapeutic vs. Day One Biopharmaceuticals | Sage Therapeutic vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |